Samar Priyank, Dhawale Tanvi A, Pandya Sarla
Anesthesiology, K.J. Somaiya Medical College and Hospital, Mumbai, IND.
Cureus. 2020 Oct 2;12(10):e10768. doi: 10.7759/cureus.10768.
Background Dexmedetomidine is being used as an adjuvant analgesic, both as intravenous (IV) and intrathecal infusion. The role of perineural (P) dexmedetomidine has evoked attention recently. The aim of this study was to compare the effect of IV dexmedetomidine and P dexmedetomidine as an adjunct to supraclavicular brachial plexus block in upper limb orthopaedic surgery. Methods Patients were randomly divided into two equal groups (n=20). Group I (IV dexmedetomidine) received dexmedetomidine 1 mcg/kg IV as loading dose over 10 minutes, followed by continuous infusion of dexmedetomidine 0.4 mcg/kg/hr IV. Group P (P dexmedetomidine) received dexmedetomidine at 1 mcg/kg perineurally. After adequate motor response with the aid of peripheral nerve stimulator a supraclavicular block with 40 ml solution containing 5 mg/kg lignocaine (2%) with adrenaline (1:200,000) and 2 mg/kg of bupivacaine (0.5%) was injected to both the groups. Group P also received dexmedetomidine perineurally with block. Onset and duration of sensory and motor block, Ramsay sedation score, hemodynamic parameters, and postoperative analgesia requirement were assessed along with side effects. The data obtained were recorded as mean ± SD, ranges, numbers, and ratios. Results were analyzed using the chi-square test, the Mann-Whitney test for non-parametric data, and an unpaired 't'-test for parametric data. Statistical analysis was carried out using the SPSS (version 10, 2002; SPSS Inc., Chicago, IL, USA) for Windows statistical package. P value less than 0.05 was considered statistically significant. Results Mean onset of sensory block was earlier in group I than in group P (p<0.05) although mean onset of motor block was not significantly different (p>0.05). Duration of sensory and motor blockade was longer in group I (p<0.05). Patients in group I demonstrated lower pulse rate and lower systolic and diastolic blood pressures throughout the period with comparable SpO values. There was no difference in intraoperative Ramsay sedation scores in both groups, but postoperative Ramsay sedation scores at 9, 12, and 15 hours were better in group I (p<0.05). The average time to rescue analgesia (visual analogue scale >4) was higher in group I (p>0.05). Conclusion IV dexmedetomidine produced early onset of sensory block, longer duration of sensory and motor block, and longer duration of analgesia as compared with P dexmedetomidine as an adjuvant to supraclavicular block with 5 mg/kg lignocaine (2%) and 2 mg/kg bupivacaine (0.5%) in upper limb orthopaedic surgeries.
背景 右美托咪定正被用作辅助镇痛药,可通过静脉注射(IV)和鞘内输注两种方式给药。神经周围(P)注射右美托咪定的作用最近引起了关注。本研究的目的是比较静脉注射右美托咪定和神经周围注射右美托咪定作为上肢骨科手术中锁骨上臂丛神经阻滞辅助用药的效果。方法 将患者随机分为两组,每组20例。第一组(静脉注射右美托咪定组)在10分钟内静脉注射负荷剂量的右美托咪定1 mcg/kg,随后以0.4 mcg/kg/hr的速度持续静脉输注。P组(神经周围注射右美托咪定组)神经周围注射右美托咪定1 mcg/kg。在周围神经刺激器的辅助下获得足够的运动反应后,两组均注射含5 mg/kg利多卡因(2%)和肾上腺素(1:200,000)以及2 mg/kg布比卡因(0.5%)的40 ml溶液进行锁骨上阻滞。P组在阻滞时也神经周围注射右美托咪定。评估感觉和运动阻滞的起效时间和持续时间、Ramsay镇静评分、血流动力学参数、术后镇痛需求以及副作用。所获得的数据记录为均值±标准差、范围、数量和比例。使用卡方检验、非参数数据的Mann-Whitney检验以及参数数据的非配对“t”检验进行结果分析。使用适用于Windows的SPSS统计软件包(版本10,2002;SPSS公司,美国伊利诺伊州芝加哥)进行统计分析。P值小于0.05被认为具有统计学意义。结果 第一组感觉阻滞的平均起效时间早于P组(p<0.05),尽管运动阻滞的平均起效时间无显著差异(p>0.05)。第一组感觉和运动阻滞的持续时间更长(p<0.05)。在整个时间段内,第一组患者的脉搏率、收缩压和舒张压较低,SpO值相当。两组术中Ramsay镇静评分无差异,但第一组术后9、12和15小时的Ramsay镇静评分更好(p<0.05)。第一组至补救性镇痛(视觉模拟评分>4)的平均时间更长(p>0.05)。结论 在上肢骨科手术中,作为含5 mg/kg利多卡因(2%)和2 mg/kg布比卡因(0.5%)的锁骨上阻滞的辅助用药,静脉注射右美托咪定比神经周围注射右美托咪定产生更早的感觉阻滞起效时间、更长的感觉和运动阻滞持续时间以及更长的镇痛持续时间。